Home / Pharma news / US FDA approves Novartis’ Rydapt

US FDA approves Novartis’ Rydapt

The US Food and Drug Administration (FDA) has approved Novartis’ Rydapt (midostaurin, formerly PKC412) for two indications.

Read more @ http://www.pharmabiz.com/NewsDetails.aspx?aid=101706&sid=2

Check Also

New Vaccine teaches immune system to attack Cancer !

Researchers at Mount Sinai in the US have developed a new immunotherapy that can be ...

%d bloggers like this: